Volume Spike Investor

Sinovac Biotech Ltd. (AMEX: SVA) is soaring after China approved it for a vaccine against swine flu for the Chinese market. This stock had been on fire already because of regional approval and because of positive swine flu data seen in studies.  This closed at $8.53 yesterday and at 8:28 AM EST we have already seen 600,000 shares trade hands.  The last print is up 16% at $9.93 and the 52-week high is $%12.50.  Average volume is now over 3 million shares, and you can expects that to be surpassed shortly after the open. -JON OGG